Canaan Partners invests in entrepreneurs and works alongside them to turn visionary ideas into valuable companies. Since 1987, the firm has catalyzed the growth of disruptive technology startups and healthcare companies revolutionizing the practice of medicine. Canaan maintains a presence in the global innovation hubs of New York, Silicon Valley and Israel with $4.2 billion under management and over 180 exits to date.
5AM Ventures is a leading venture capital firm focused on building next-generation life science companies capable of delivering outstanding returns to investors. 5AM Ventures supports companies solving important healthcare needs via cutting-edge breakthroughs in medicine and science. 5AM Ventures portfolio companies spearhead novel approaches to diagnose, prevent and treat a wide range of medical conditions. The firm has offices in Menlo Park, CA and Waltham, MA.
RA Capital Management, LLC (“RA Capital”) is a crossover fund manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices and diagnostics. The flexibility of its strategy allows RA Capital to lead private, IPO and follow-on financings for its portfolio companies, both facilitating the crossover process and allowing management teams to drive value creation with fewer capital concerns from inception through commercialization.
From biopharmaceuticals to medical devices, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer and more productive lives. We have been investing globally for over 20 years across the healthcare industry: from early-stage private companies to large multinational corporations. Our team of over 80 distinguished scientific, medical, investment and other professionals manage approximately $15 billion across public and private company investments worldwide.
New Leaf Venture Partners
New Leaf Venture Partners was formed in 2005, when the healthcare team spun out of the Sprout Group. The NLVP team has been built over the last two decades and managed healthcare technology portfolios in four Sprout funds and four New Leaf funds. We partner with companies across all phases, from startup to public offerings, as we look to invest in visionary teams, businesses at the forefront of biology and innovation, and disruptive healthcare technologies across the entire healthcare system. And we share our broad perspectives, decades of experience and deep domain expertise to help our portfolio companies navigate the complexity of the healthcare industry.
Nextech Invest Ltd.
Nextech is a leading, global oncology investment firm that specializes on early, private-stage cancer companies. The firm is led by an entrepreneurial investment group with extensive biotech and early venture experience, working closely with a dedicated Scientific Board of oncology experts to evaluate and realize the most promising opportunities in the industry. Owing to its specialized approach and strategy, the Nextech team accesses world-class investment targets to advance validated, first-in class scientific breakthroughs for the benefit of cancer patients across the world.
Deerfield is an investment management firm committed to advancing healthcare through investment, information and philanthropy.
Hillhouse Capital Group
Founded in 2005, Hillhouse Capital is a global firm of investment professionals and operating executives who are focused on building and investing in high quality business franchises that achieve sustainable growth. Independent proprietary research and industry expertise, in conjunction with world-class operating and management capabilities, are key to Hillhouse Capital’s investment approach. Hillhouse Capital partners with exceptional entrepreneurs and management teams to create value, often with a focus on enacting innovation and technological transformation. Hillhouse Capital invests in the healthcare, consumer, TMT, advanced manufacturing, financials and business services sectors in companies across all equity stages. Hillhouse Capital and its group members manage over US$35 billion in assets on behalf of institutional clients such as university endowments, foundations, sovereign wealth funds, and family offices.
Elm Street Ventures
Elm Street Ventures is a seed and early stage venture fund based in New Haven, Connecticut. Elm Street Ventures’ emphasis is on the life sciences, with approximately 70% of the investments to date in companies developing laboratory tools, diagnostics, medical devices, therapeutics and other healthcare related products and services. The remaining 30% of the commitments are in green technology, information technology and other industries.
Connecticut Innovations (CI) is the leading source of financing and ongoing support for Connecticut’s innovative, growing companies. To maximize each business’s growth potential, CI tailors its solutions and often combines its funds with resources from other financial leaders to provide venture capital and strategic support for early stage technology companies; flexible loans and grants that support innovation and collaboration; and connections to its well-established network of partners and professionals. CI has helped bring $4 billion in financing to Connecticut companies.